Cargando…
The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
SIMPLE SUMMARY: Cancer remains a serious health problem owing to its high morbidity and mortality. Immunotherapy, represented by anti-programmed death-1D1/anti-PD-Ligand 1 treatments, has become one of the most important methods for cancer treatment. However, there are still some challenges in this...
Autores principales: | Tang, Xi-Yang, Luo, Zhong-Lin, Xiong, Yan-Lu, Yang, Jie, Shi, An-Ping, Zheng, Kai-Fu, Liu, Yu-Jian, Shu, Chen, Ma, Nan, Lu, Qiang, Zhao, Jin-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657406/ https://www.ncbi.nlm.nih.gov/pubmed/36358792 http://dx.doi.org/10.3390/cancers14215374 |
Ejemplares similares
-
Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
por: Tang, Xi-Yang, et al.
Publicado: (2022) -
Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis
por: Tang, Xi-Yang, et al.
Publicado: (2021) -
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022) -
IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
por: Tang, Xi-Yang, et al.
Publicado: (2022) -
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
por: Pabla, Sarabjot, et al.
Publicado: (2019)